TrialESC heart failure2022

Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial.

Anthony Mathur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.